StemCells, Inc. announces results of spinal cord injury trial – gains in sensory function persist 12 months after stem cell transplant

StemCells Inc. have announced the 12-month results of their initial Phase I safety trial of purified human neural stem cells for chronic spinal cord injury. The sensory improvements reported at 6-months have persisted and not adverse effects have be seen.

I should be remembered that this was just a safety trial with very few cells actually injected, so the return of feeling in people with complete chronic injuries is very encouraging.

“While we need to be cautious when interpreting data from a small, uncontrolled trial, to our knowledge, this is the first time a patient with a complete spinal cord injury has been converted to a patient with an incomplete injury following transplantation of neural stem cells,” StemCells President and CEO Martin McGlynn said.

Read more…

StemCells, Inc. announces results of spinal cord injury trial – gains in sensory function persist 12 months after stem cell transplant